Concepedia

George J. Klarmann

GJ

22

Publications

2.5K

Citations

18

H-Index

1993

Active since

Affiliations

National Cancer Institute(Current)

Science Applications International Corporation (United States)

University of Utah

CFD Research Corporation (United States)

United States Army Medical Research and Development Command

George J. Klarmann is an author at National Cancer Institute specializing in medicine, engineering, and cell biology.

ORCID

Top concepts

Publications per year

1993–2023

22

Publications

22

CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

Elaine M. Hurt, Brian T. Kawasaki, George J. Klarmann et al. · British Journal of Cancer · 2008 · 434 citations · Full text

High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome

Amanda E. Jetzt, Hong Yu, George J. Klarmann et al. · Journal of Virology · 2000 · 375 citations · Full text

Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots

Jianling Zhuang, Amanda E. Jetzt, Guoli Sun et al. · Journal of Virology · 2002 · 257 citations · Full text

, , +17

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

George J. Klarmann, Elaine M. Hurt, Lesley Mathews et al. · Clinical & Experimental Metastasis · 2009 · 220 citations · Full text

, , +8

Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro

George J. Klarmann, Cherylene Schauber, B D Preston · Journal of Biological Chemistry · 1993 · 203 citations · Full text

, , +19

Rows per page

1–5 of 22